{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:24:40Z","timestamp":1770337480309,"version":"3.49.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is a neurodegenerative disease that seriously affects human health, and current treatment strategies are far from meeting clinical needs. Inspired by multi-target drug design strategies, a series of novel natural products-based melatonin\u2013hydroxyquinoline hybrids were designed and synthesized, targeting anti-oxidation and metal-chelating at the same time. Most of the compounds showed significant oxygen radical absorbance capacity and A\u03b2<jats:sub>1\u201342<\/jats:sub> aggregation inhibition. Moreover, the compounds possess good blood-brain barrier permeability. <jats:bold>6b<\/jats:bold> and <jats:bold>6c<\/jats:bold> have a good ability to alleviate oxidative stress induced by hydrogen peroxide. <jats:bold>6b<\/jats:bold> and <jats:bold>6c<\/jats:bold> possess metal-chelating properties with the chelation ratio being 2:1. Furthermore, <jats:bold>6b<\/jats:bold> can significantly mitigate metal-induced A\u03b2 aggregation. This work may provide a new multi-target treatment strategy for Alzheimer\u2019s disease.<\/jats:p>","DOI":"10.3389\/fchem.2024.1374930","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T09:19:11Z","timestamp":1713259151000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Discovery of novel melatonin\u2013mydroxyquinoline hybrids as multitarget strategies for Alzheimer\u2019s disease therapy"],"prefix":"10.3389","volume":"12","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wandi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","article-title":"Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial A\u03b2","volume":"59","author":"Adlard","year":"2008","journal-title":"Neuron"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/alz.12328","article-title":"Alzheimer's disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimers Dement."},{"key":"B3","doi-asserted-by":"publisher","first-page":"895483","DOI":"10.3389\/fchem.2022.895483","article-title":"Novel coumarin-pyridine hybrids as potent multi-target directed ligands aiming at symptoms of Alzheimer's disease","volume":"10","author":"Babaei","year":"2022","journal-title":"Front. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fneur.2012.00073","article-title":"Behavioral and psychological symptoms of dementia","volume":"3","author":"Cerejeira","year":"2012","journal-title":"Front. Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/s0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1532-5415.2007.01543.x","article-title":"Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease","volume":"56","author":"Dowling","year":"2008","journal-title":"J. Am. Geriatr. Soc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3233\/jad-2010-1390","article-title":"PBT2 rapidly improves cognition in Alzheimer's disease: additional phase II analyses","volume":"20","author":"Faux","year":"2010","journal-title":"J. Alzheimers. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"9146","DOI":"10.1021\/jm3003813","article-title":"Liberation of copper from amyloid plaques: making a risk factor useful for Alzheimer's disease treatment","volume":"55","author":"Geng","year":"2012","journal-title":"J. Med. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"918116","DOI":"10.3389\/fchem.2022.918116","article-title":"Synthesis of melatonin derivatives and the neuroprotective effects on Parkinson's disease models of Caenorhabditis elegans","volume":"10","author":"He","year":"2022","journal-title":"Front. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ejmech.2018.12.013","article-title":"Synthesis and evaluation of clioquinol-rolipram\/roflumilast hybrids as multitarget-directed ligands for the treatment of Alzheimer's disease","volume":"163","author":"Hu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.1021\/jm400567s","article-title":"Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer's disease","volume":"56","author":"Lu","year":"2013","journal-title":"J. Med. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"12603","DOI":"10.1021\/acs.jmedchem.1c00497","article-title":"Multifunctional arylsulfone and arylsulfonamide-based ligands with prominent mood-modulating activity and benign safety profile, targeting neuropsychiatric symptoms of dementia","volume":"64","author":"Marcinkowska","year":"2021","journal-title":"J. Med. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/jpi.12360","article-title":"Melatonin as an antioxidant: under promises but over delivers","volume":"61","author":"Reiter","year":"2016","journal-title":"J. Pineal Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1021\/jm800577j","article-title":"Inhibition of acetylcholinesterase, \u03b2-amyloid aggregation, and nmda receptors in Alzheimer\u2019s disease: a promising direction for the multi-target-directed ligands gold rush","volume":"51","author":"Rosini","year":"2008","journal-title":"J. Med. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4972","DOI":"10.1021\/acs.jmedchem.1c00048","article-title":"Sustainable drug discovery of multi-target-directed ligands for Alzheimer's disease","volume":"64","author":"Rossi","year":"2021","journal-title":"J. Med. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/s0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"11229","DOI":"10.1021\/acs.jmedchem.2c00717","article-title":"Design and validation of the first family of photo-activatable ligands for melatonin receptors","volume":"65","author":"Somalo-Barranco","year":"2022","journal-title":"J. Med. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"12292","DOI":"10.1021\/acs.jmedchem.2c01003","article-title":"Discovery of potent cholinesterase inhibition-based multi-target-directed lead compounds for synaptoprotection in Alzheimer's disease","volume":"65","author":"Turgutalp","year":"2022","journal-title":"J. Med. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1021\/acs.jmedchem.7b01417","article-title":"Design, synthesis, and evaluation of orally bioavailable quinoline\u2013indole derivatives as innovative multitarget-directed ligands: promotion of cell proliferation in the adult murine Hippocampus for the treatment of Alzheimer\u2019s disease","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1021\/cn500119g","article-title":"Design, synthesis, and evaluation of multitarget-directed selenium-containing clioquinol derivatives for the treatment of Alzheimer\u2019s disease","volume":"5","author":"Wang","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"8616","DOI":"10.1021\/acs.jmedchem.5b01222","article-title":"Design, synthesis, and evaluation of orally available clioquinol-moracin M hybrids as multitarget-directed ligands for cognitive improvement in a rat model of neurodegeneration in Alzheimer\u2019s disease","volume":"58","author":"Wang","year":"2015","journal-title":"J. Med. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"120671","DOI":"10.1016\/j.ijpharm.2021.120671","article-title":"Reduction-responsive dehydroepiandrosterone prodrug nanoparticles loaded with camptothecin for cancer therapy by enhancing oxidation therapy and cell replication inhibition","volume":"603","author":"Xu","year":"2021","journal-title":"Int. J. Pharm."}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2024.1374930\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T09:19:13Z","timestamp":1713259153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2024.1374930\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":22,"alternative-id":["10.3389\/fchem.2024.1374930"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2024.1374930","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,16]]},"article-number":"1374930"}}